These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7906568)

  • 1. [Blood-transfusion in Vietnam].
    Nakada S
    Nihon Koshu Eisei Zasshi; 1994 Jan; 41(1):95-100. PubMed ID: 7906568
    [No Abstract]   [Full Text] [Related]  

  • 2. Residual risk of transfusion transmitted viral infections among seronegative donors: application of the incidence/window period model.
    Kleinman S
    Dev Biol (Basel); 2000; 102():61-5. PubMed ID: 10794091
    [No Abstract]   [Full Text] [Related]  

  • 3. Transfusion-dependent thalassemia: viral complications (epidemiology and follow-up).
    de Montalembert M; Girot R; Mattlinger B; Lefrère JJ
    Semin Hematol; 1995 Oct; 32(4):280-7. PubMed ID: 8560285
    [No Abstract]   [Full Text] [Related]  

  • 4. [Residual risk of infections transmitted by blood component transfusion].
    Couroucé AM
    Rev Epidemiol Sante Publique; 1994; 42(5):463-6. PubMed ID: 7973006
    [No Abstract]   [Full Text] [Related]  

  • 5. Transfusion-transmitted viral infections. Retrovirus and Viral Hepatitis Working Groups of the French Society of Blood Transfusion.
    Couroucé AM; Pillonel J
    N Engl J Med; 1996 Nov; 335(21):1609-10. PubMed ID: 8927113
    [No Abstract]   [Full Text] [Related]  

  • 6. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
    Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
    Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study.
    Schreiber GB; Busch MP; Kleinman SH; Korelitz JJ
    N Engl J Med; 1996 Jun; 334(26):1685-90. PubMed ID: 8637512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Transfusion safety].
    Aprili G
    Haematologica; 1991 Jun; 76 Suppl 3():385-94. PubMed ID: 1752537
    [No Abstract]   [Full Text] [Related]  

  • 9. Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy.
    Gonzalez M; Règine V; Piccinini V; Vulcano F; Giampaolo A; Hassan HJ
    Transfusion; 2005 Oct; 45(10):1670-5. PubMed ID: 16181219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probability of viremia with HBV, HCV, HIV, and HTLV among tissue donors in the United States.
    Zou S; Dodd RY; Stramer SL; Strong DM;
    N Engl J Med; 2004 Aug; 351(8):751-9. PubMed ID: 15317888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infectivity of human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion.
    Kleinman SH; Lelie N; Busch MP
    Transfusion; 2009 Nov; 49(11):2454-89. PubMed ID: 19682345
    [No Abstract]   [Full Text] [Related]  

  • 12. [Viral safety of blood and blood products].
    Gürtler L
    Fortschr Med; 1993 Nov; 111(33):526-7. PubMed ID: 8307536
    [No Abstract]   [Full Text] [Related]  

  • 13. Current issues in blood component therapy: transmission of infectious diseases.
    Menitove JE
    Oncology (Williston Park); 1987 Jun; 1(4):21-30. PubMed ID: 2856350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Transfusion-induced virus infections: how great is the risk?].
    Sibrowski W; Penner M; Kühnl P
    Infusionsther Transfusionsmed; 1993 Jun; 20 Suppl 2():4-9. PubMed ID: 8374287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of the Ministry of Health in the prevention of diseases caused by blood transfusion].
    Wolpert Barraza E; Córdova MS; Robles Díaz G; Reyes López PA
    Gac Med Mex; 1994; 130(6):412-24. PubMed ID: 7557054
    [No Abstract]   [Full Text] [Related]  

  • 16. Does prevalence of transfusion-transmissible viral infection reflect corresponding incidence in United States blood donors?
    Wang B; Schreiber GB; Glynn SA; Kleinman S; Wright DJ; Murphy EL; Busch MP;
    Transfusion; 2005 Jul; 45(7):1089-96. PubMed ID: 15987352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B, hepatitis C and HIV transfusion-transmitted infections in the 21st century.
    Dwyre DM; Fernando LP; Holland PV
    Vox Sang; 2011 Jan; 100(1):92-8. PubMed ID: 21175659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-transfusion hepatitis and serum alanine aminotransferase in blood donors.
    N Engl J Med; 1981 Aug; 305(7):403-4. PubMed ID: 6789203
    [No Abstract]   [Full Text] [Related]  

  • 19. Infectious markers in blood donors of East Delhi: prevalence and trends.
    Singh B; Kataria SP; Gupta R
    Indian J Pathol Microbiol; 2004 Oct; 47(4):477-9. PubMed ID: 16295370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infectious pathogens in volunteer and replacement blood donors in Pakistan: a ten-year experience.
    Sultan F; Mehmood T; Mahmood MT
    Int J Infect Dis; 2007 Sep; 11(5):407-12. PubMed ID: 17331775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.